Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:27PM EDT. Market open.
| Previous close | 226.01 |
| Open | 223.26 |
| Bid | 227.46 x 800 |
| Ask | 227.66 x 800 |
| Day's range | 224.41 - 230.00 |
| 52-week range | 203.37 - 460.21 |
| Volume | |
| Avg. volume | 549,985 |
| Market cap | 11.546B |
| Beta (5Y monthly) | 1.27 |
| PE ratio (TTM) | 27.18 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
WILMINGTON, Mass. & MACCLESFIELD, England, June 28, 2022--Charles River announces the opening of their High Quality Plasmid DNA Centre of Excellence at Bruntwood SciTech’s Alderley Park.
- Business Wire
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
WILMINGTON, Mass. & GHENT, Belgium, June 23, 2022--Charles River and Ziphius Vaccines collaborate to deliver early-stage clinical supply of plasmid DNA for saRNA-based vaccine program.
- Business Wire
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
WILMINGTON, Mass., June 13, 2022--Charles River and ASC Therapeutics announce expanded relationship to scale manufacturing for a second generation gene therapy for hemophilia A.
© 2022 Yahoo. All rights reserved.
